Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7931 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7908 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7831 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7771 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7687 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7674 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7662 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7661 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7627 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7588 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD8435 |
Approved |
0.7586 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7586 |
Intermediate Similarity |
NPD8361 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD7003 |
Approved |
0.74 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7399 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7399 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.7325 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7312 |
Intermediate Similarity |
NPD6273 |
Approved |
0.731 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7303 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.7229 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7183 |
Intermediate Similarity |
NPD5951 |
Approved |
0.717 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7152 |
Intermediate Similarity |
NPD37 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7126 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7123 |
Intermediate Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7108 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7097 |
Intermediate Similarity |
NPD7497 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD7240 |
Approved |
0.6982 |
Remote Similarity |
NPD7075 |
Discontinued |
0.697 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD5408 |
Approved |
0.6962 |
Remote Similarity |
NPD5404 |
Approved |
0.6962 |
Remote Similarity |
NPD5406 |
Approved |
0.6962 |
Remote Similarity |
NPD5405 |
Approved |
0.6959 |
Remote Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6928 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6919 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6901 |
Remote Similarity |
NPD5494 |
Approved |
0.6894 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6893 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6892 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD7411 |
Suspended |
0.6879 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD2182 |
Approved |
0.6878 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6878 |
Remote Similarity |
NPD8319 |
Approved |
0.6871 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD5402 |
Approved |
0.686 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.686 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6852 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD6535 |
Approved |
0.6848 |
Remote Similarity |
NPD6534 |
Approved |
0.6839 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6839 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6825 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6815 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6813 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6806 |
Remote Similarity |
NPD6858 |
Approved |
0.6806 |
Remote Similarity |
NPD7094 |
Approved |
0.6805 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6805 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6804 |
Remote Similarity |
NPD8462 |
Phase 1 |
0.68 |
Remote Similarity |
NPD6287 |
Discontinued |
0.6795 |
Remote Similarity |
NPD7715 |
Approved |
0.6795 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6795 |
Remote Similarity |
NPD7714 |
Approved |
0.6795 |
Remote Similarity |
NPD6663 |
Approved |
0.6795 |
Remote Similarity |
NPD7713 |
Phase 3 |
0.679 |
Remote Similarity |
NPD3750 |
Approved |
0.6789 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6789 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6782 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6768 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6766 |
Remote Similarity |
NPD3226 |
Approved |
0.6765 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6759 |
Remote Similarity |
NPD4869 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD5736 |
Approved |
0.675 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6747 |
Remote Similarity |
NPD5403 |
Approved |
0.6746 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6736 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6731 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6727 |
Remote Similarity |
NPD2533 |
Approved |
0.6727 |
Remote Similarity |
NPD2534 |
Approved |
0.6727 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6727 |
Remote Similarity |
NPD2532 |
Approved |
0.6727 |
Remote Similarity |
NPD5401 |
Approved |
0.6723 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6712 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6709 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6708 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6706 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6704 |
Remote Similarity |
NPD6764 |
Approved |
0.6704 |
Remote Similarity |
NPD6765 |
Approved |
0.6701 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6701 |
Remote Similarity |
NPD7874 |
Approved |
0.6687 |
Remote Similarity |
NPD3748 |
Approved |
0.6686 |
Remote Similarity |
NPD3749 |
Approved |
0.6686 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6685 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6684 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD6777 |
Approved |
0.6667 |
Remote Similarity |
NPD1238 |
Approved |
0.6667 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6781 |
Approved |
0.6667 |
Remote Similarity |
NPD6780 |
Approved |
0.6667 |
Remote Similarity |
NPD7095 |
Approved |
0.6667 |
Remote Similarity |
NPD6776 |
Approved |
0.6667 |
Remote Similarity |
NPD7798 |
Approved |
0.6667 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6667 |
Remote Similarity |
NPD6779 |
Approved |
0.6667 |
Remote Similarity |
NPD6782 |
Approved |
0.6667 |
Remote Similarity |
NPD6799 |
Approved |
0.6667 |
Remote Similarity |
NPD6778 |
Approved |
0.6649 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6649 |
Remote Similarity |
NPD7698 |
Approved |
0.6649 |
Remote Similarity |
NPD7697 |
Approved |
0.6648 |
Remote Similarity |
NPD7997 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD1934 |
Approved |
0.6646 |
Remote Similarity |
NPD2438 |
Suspended |
0.6643 |
Remote Similarity |
NPD1930 |
Approved |
0.6643 |
Remote Similarity |
NPD1929 |
Approved |
0.6643 |
Remote Similarity |
NPD1931 |
Clinical (unspecified phase) |
0.6629 |
Remote Similarity |
NPD7054 |
Approved |
0.6629 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6629 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6627 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6608 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6598 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6596 |
Remote Similarity |
NPD164 |
Approved |
0.6592 |
Remote Similarity |
NPD7472 |
Approved |
0.6591 |
Remote Similarity |
NPD8051 |
Clinical (unspecified phase) |
0.6587 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6585 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6585 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6584 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6582 |
Remote Similarity |
NPD8032 |
Phase 2 |
0.6582 |
Remote Similarity |
NPD7801 |
Approved |
0.6575 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6573 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6573 |
Remote Similarity |
NPD3751 |
Discontinued |
0.657 |
Remote Similarity |
NPD8438 |
Clinical (unspecified phase) |
0.6562 |
Remote Similarity |
NPD7680 |
Approved |
0.6557 |
Remote Similarity |
NPD6784 |
Approved |
0.6557 |
Remote Similarity |
NPD6785 |
Approved |
0.6552 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6535 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6533 |
Remote Similarity |
NPD9545 |
Approved |
0.6532 |
Remote Similarity |
NPD3882 |
Suspended |
0.6529 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6524 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6524
|
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |